Healthcare -
Biotechnology - NASDAQ - US
$ 243.34
-1.38 %
$ 31.5 B
Market Cap
-112.14
P/E
ALNY - ACCOUNTS PAYABLE
Accounts Payable ALNY - Alnylam Pharmaceuticals, Inc.
88.4 M
LAST VALUE
-5.06%
2 YEAR CAGR
12.13%
5 YEAR CAGR
19.32%
10 YEAR CAGR